Thermo Fisher Scientific Share Price Deutsche Boerse AG
Equities
TN8
US8835561023
Advanced Medical Equipment & Technology
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
549.4 EUR | +0.68% | +1.95% | +13.96% |
Sales 2024 * | 43.01B 39.71B 3,411B | Sales 2025 * | 46.08B 42.55B 3,655B | Capitalization | 227B 210B 18,010B |
---|---|---|---|---|---|
Net income 2024 * | 6.11B 5.64B 485B | Net income 2025 * | 7B 6.46B 555B | EV / Sales 2024 * | 5.84 x |
Net Debt 2024 * | 23.99B 22.15B 1,903B | Net Debt 2025 * | 19.18B 17.71B 1,522B | EV / Sales 2025 * | 5.34 x |
P/E ratio 2024 * |
37.6
x | P/E ratio 2025 * |
32
x | Employees | 122,000 |
Yield 2024 * |
0.25% | Yield 2025 * |
0.27% | Free-Float | 86.04% |
Latest transcript on Thermo Fisher Scientific
1 day | +0.68% | ||
1 week | +1.95% | ||
Current month | +1.44% | ||
1 month | +2.24% | ||
3 months | +6.62% | ||
6 months | +25.99% | ||
Current year | +13.96% |
Managers | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 31/10/01 |
Director of Finance/CFO | 57 | 31/05/01 | |
Ryan Snyder
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 31/10/01 |
C. Harris
BRD | Director/Board Member | 67 | 29/03/12 |
Ruby Chandy
BRD | Director/Board Member | 62 | 28/02/22 |
Date | Price | Change | Volume |
---|---|---|---|
15/05/24 | 547.8 | +0.38% | 0 |
14/05/24 | 545.7 | -0.38% | 0 |
13/05/24 | 547.8 | -0.24% | 22 |
10/05/24 | 549.1 | +2.54% | 47 |
09/05/24 | 535.5 | -0.34% | 30 |
Delayed Quote Deutsche Boerse AG, May 15, 2024 at 07:01 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.07% | 192B | |
+13.88% | 136B | |
+27.12% | 108B | |
+0.76% | 64.07B | |
+13.39% | 52.1B | |
+6.74% | 51.87B | |
+8.81% | 44.33B | |
+4.14% | 36.75B | |
+25.48% | 31.71B |
- Stock Market
- Equities
- TMO Stock
- TN8 Stock